glp-1 and anastrozole How medications are transforming diabetes weight loss treatment The Impact and Safety of

Use of older agents declined as the newer drugs displaced them

When you eat, it prompts your gut to release the GLP-1 hormone

Considering GLP-1 Therapy or Fatty Liver Risk Evaluation

Obesity is now very common among patients with Crohns disease, yet there is limited guidance on how newer metabolic medications, particularly GLP-1 receptor agonists affect Crohns-related outcomes, presenting author Nakul Ganju, MD, an internal medicine resident at Howard University Hospital in Washington, DC, told GI & Hepatology News

Bain SC, Mosenzon O, Arechavaleta R et al

Pancreatitis risk associated with GLP-1 receptor agonists, considered as a single class, in a comorbidity-free subgroup of type 2 diabetes patients in the United States: a propensity score-matched analysis